Li Jerry

5PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 12, 2026
Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid Tumors.

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Oct 23, 2025
Application of Machine Learning for Predicting Progression-Free and Overall Survival in Patients With Renal Cell Carcinoma.

Caroline W Grant, Jerry Li, Swan Lin

|Jun 13, 2024
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.

Li Jerry, Lin Swan, Nickens Dana

|May 03, 2021
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants.

Jerry Li, Yazdi K Pithavala, Jason Gong

Pageof 1

Frequent Collaborators

1 joint publications

Yazdi K Pithavala

1 joint publications

Josué Kunjom Mfopou

1 joint publications

Joseph Chen

1 joint publications

Caroline W Grant